Comments

Compass Therapeutics Insider Trading Activity

CMPXNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$2.10
0.041.94%
At close: -
$2.14
0.041.90%
After Hours: 5:54 PM EDT
Compass Therapeutics (CMPX) ForecastNewsEarningsCompass Therapeutics (CMPX) OptionsGuidanceDividendsAnalyst Ratings

Insider Trades

Short Interest

Compass Therapeutics Insider Trading Activity | NASDAQ:CMPX | Benzinga

Track the latest Compass Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Compass Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Compass Therapeutics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

  • On April 8, 2025, Jonathan Anderman, the company's GEN COUNSEL & CORPORATE SEC purchased 20K shares for $1.54 each.
  • On April 8, 2025, Neil Lerner, the company's CHIEF ACCOUNTING OFFICER purchased 20K shares for $1.42 each.
  • On April 11, 2025, Carl L Gordon, the company's DIRECTOR sold 3.57M shares for $1.59 each.

Ownership Statistics for Compass Therapeutics Inc

Shares Outstanding
137.589M
Insider Shares Owned
12.162M
Insider Percentage Owned
8.80%
Institutional Shares Held
20.287M
Institutional Percentage Held
14.7%
Apr 11, 2025Carl L GordonDIRECTOR-3.57M$1.59-$5.68MSELL-19.01%15.22MApr 09View
Apr 11, 2025ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Genesis GP LLCDIRECTOR-3.57M$1.59-$5.68MSELL-19.01%15.22MApr 09View
Apr 08, 2025Jonathan AndermanGEN COUNSEL & CORPORATE SEC20.00K$1.54$30.80KBUY2000.00%21.00KApr 07View
Apr 08, 2025Neil LernerCHIEF ACCOUNTING OFFICER20.00K$1.42$28.40KBUY6.67%320.00KApr 07View
Mar 10, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER10.00K$3.37$33.70KBUY0.17%6.02MMar 10View
Feb 27, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.00K$3.98$79.60KBUY0.33%6.01MFeb 27View
Feb 15, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.00K$3.86$77.20KBUY0.33%5.99MFeb 15View
Jan 31, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.00K$4.05$81.00KBUY0.37%5.47MJan 31View
Jan 24, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.00K$4.19$83.80KBUY0.37%5.45MJan 24View
Nov 25, 2022Vered Bisker-LeibCHIEF OPERATING OFFICER-24.50K$4.23-$103.71KSELL-2.26%1.06MNov 22 - Nov 25View
Nov 22, 2022Vered Bisker-LeibCHIEF OPERATING OFFICER-22.26K$4.36-$96.99KSELL-2.01%1.08MNov 18 - Nov 21View
Nov 10, 2022ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Genesis GP LLCDIRECTOR402.00K$3.21$1.29MBUY2.19%18.79MNov 08View
Nov 10, 2022Carl GordonDIRECTOR402.00K$3.21$1.29MBUY2.19%18.79MNov 08View
Sep 28, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER10.00K$2.32$23.20KBUY0.18%5.43MSep 28View
Sep 27, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15.00K$2.27$34.05KBUY0.28%5.42MSep 26View
Sep 08, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15.00K$3.03$45.45KBUY0.28%5.41MSep 07View
Sep 01, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15.00K$2.83$42.45KBUY0.28%5.39MSep 01View
Aug 17, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15.00K$3.05$45.75KBUY0.28%5.38MAug 17View
Aug 10, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15.00K$2.64$39.60KBUY0.28%5.36MAug 10View
Aug 02, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15.00K$2.58$38.70KBUY0.28%5.35MAug 01View
Jun 21, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.00K$2.80$56.00KBUY0.38%5.33MJun 21View
Jun 17, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.00K$2.34$46.80KBUY0.38%5.31MJun 16View
Jun 13, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER30.00K$2.29$68.70KBUY0.57%5.29MJun 13View
Jun 07, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER30.00K$2.83$84.90KBUY0.57%5.26MJun 06View
Jun 01, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.00K$3.03$60.60KBUY0.38%5.23MJun 01View
May 26, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.00K$3.04$60.80KBUY0.39%5.21MMay 26View
May 24, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER18.36K$2.72$49.93KBUY0.35%5.19MMay 23View
May 17, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.21K$2.47$49.93KBUY0.39%5.17MMay 17View
May 13, 2022Carl Gordon Member of OrbiMed Advisors LLCDIRECTOR192.52K$2.18$420.48KBUY1.06%18.39MMay 11 - May 13View
May 13, 2022ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Genesis GP LLCDIRECTOR192.52K$2.18$420.48KBUY1.06%18.39MMay 11 - May 13View
May 10, 2022ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Genesis GP LLCDIRECTOR125.36K$1.57$197.25KBUY0.69%18.20MMay 06 - May 10View
May 10, 2022Carl GordonDIRECTOR125.36K$1.57$197.25KBUY0.69%18.20MMay 06 - May 10View
May 10, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER27.84K$1.80$50.10KBUY0.54%5.15MMay 10View
Nov 08, 2021Carl Gordon Member of OrbiMed Advisors LLCDIRECTOR5.36M$3.50$18.75MBUY∞3.57MNov 04View
Nov 08, 2021ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Genesis GP LLCDIRECTOR5.36M$3.50$18.75MBUY∞3.57MNov 04View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved